bromocriptine has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, K; Maekawa, A; Nishikawa, A; Suzuki, T; Takahashi, M; Taya, K; Watanabe, G; Yoshida, M | 1 |
| Martino, V; Norsa, A | 1 |
| Buytaert, P; Viaene, P | 1 |
| Blohmer, JU; Bollmann, R; Chaoui, R; Kürten, A; Lau, HU | 1 |
| Barri, PN; Dexeus, S | 1 |
| Altwein, JE; Jacobi, GH | 1 |
| Breistein, LS; Forsberg, JG | 1 |
| Baba, M; Iishi, H; Okuda, S; Taniguchi, H; Tatsuta, M | 2 |
| Biggs, PJ; Mayfield, RK; Mordes, DB; Mountcastle, RB; Rawe, SE; Roof, BS; Sagel, J | 1 |
| Bellussi, G; Conti, G; Di Carlo, F; Muccioli, G; Racca, S | 1 |
| Ip, MM; Sylvester, PW | 1 |
1 review(s) available for bromocriptine and Adenocarcinoma
| Article | Year |
|---|---|
Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.
Topics: Acromegaly; Adenocarcinoma; Animals; Bromocriptine; Cricetinae; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms | 1989 |
2 trial(s) available for bromocriptine and Adenocarcinoma
| Article | Year |
|---|---|
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status.
Topics: Adenocarcinoma; Adult; Aged; Bromocriptine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Melatonin; Middle Aged; Neoplasm Staging; Retinoids; Somatostatin; Survival Rate; Treatment Outcome; Vitamin D | 2007 |
[Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug (author's' transl)].
Topics: Adenocarcinoma; Aged; Androgens; Bromocriptine; Clinical Trials as Topic; Cyproterone; Humans; Male; Middle Aged; Palliative Care; Prolactin; Prostate; Prostatic Neoplasms; Testosterone | 1979 |
9 other study(ies) available for bromocriptine and Adenocarcinoma
| Article | Year |
|---|---|
Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Carcinogens; Endometrial Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Histocytochemistry; Hormone Antagonists; Inhibins; Luteinizing Hormone; Methylnitronitrosoguanidine; Progesterone; Prolactin; Rats | 2009 |
Amenorrhea, galactorrhea, hyperprolactinemia syndrome and breast carcinoma in a young woman.
Topics: Adenocarcinoma; Adult; Amenorrhea; Breast Neoplasms; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy; Prolactin | 1981 |
[Non-puerperal mastitis in real time and color Doppler ultrasound].
Topics: Abscess; Adenocarcinoma; Adolescent; Adult; Aged; Blood Flow Velocity; Breast; Breast Neoplasms; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Humans; Mastectomy, Segmental; Mastitis; Middle Aged; Neoplasm Recurrence, Local; Ultrasonography, Mammary | 1994 |
Hyperprolactinemia: an inductor of neoplastic changes in endometrium? A report of two cases.
Topics: Adenocarcinoma; Adult; Bromocriptine; Endometrial Neoplasms; Female; Humans; Hyperprolactinemia; Hysterectomy | 1998 |
Prolactin and 3-methylcholanthrene induced cervical carcinoma. Effect of bromocriptine.
Topics: Adenocarcinoma; Animals; Bromocriptine; Carcinoma; Castration; Cervix Uteri; Estradiol; Female; Methylcholanthrene; Mice; Neoplasms, Experimental; Prolactin; Uterine Cervical Neoplasms | 1979 |
Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Dopamine; Epinephrine; Gastric Mucosa; Gastrins; Hydrogen-Ion Concentration; Male; Methylnitronitrosoguanidine; Neoplasms, Experimental; Norepinephrine; Rats; Rats, Inbred Strains; Stomach Neoplasms | 1992 |
Inhibition by the dopamine antagonist haloperidol of experimental carcinogenesis induced by azoxymethane in rat colon.
Topics: Adenocarcinoma; Animals; Azoxymethane; Body Weight; Bromocriptine; Colonic Neoplasms; Cyclic AMP; DNA; Dopamine Antagonists; Energy Intake; Haloperidol; Male; Mitotic Index; Rats; Rats, Inbred Strains | 1991 |
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
Topics: Adenocarcinoma; Animals; Bromocriptine; Female; Liver; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Prolactin | 1988 |
Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bromocriptine; Cell Line; Drug Therapy, Combination; Haloperidol; Male; Neoplasm Transplantation; Orchiectomy; Prolactin; Prostatic Neoplasms; Rats; Tamoxifen; Testosterone | 1987 |